欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
SE/H/2203/002
药品名称
Senozam
活性成分
Midazolam 5.0 mg/ml
剂型
Solution for infusion
上市许可持有人
Eurocept International B.V. Netherlands
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Netherlands (NL)
Iceland (IS)
Germany (DE)
Senozam
许可日期
2022/12/07
最近更新日期
2024/09/27
药物ATC编码
N05CD08 midazolam
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final SPC
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20211029000061
Date of last change:2024/09/06
Final PL
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20211029000061_2
Date of last change:2024/09/06
PubAR
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20211029000061_3
Date of last change:2024/09/06
PubAR Summary
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20211029000061_4
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase